PubMed HealthSearch

Biomedical subjects

T Vuorimaa

Publications and source records attributed to T Vuorimaa.

5 recordsLinked to original sources

Changes in force production, blood lactate and EMG activity in the 400-m sprint.

The neural activation (iEMG) and selected stride characteristics of six male sprinters were studied for 100-, 200-, 300- and 400-m experimental sprints, which were run according to the velocity in the 400 m. Blood lactate (BLa) was analysed and drop jumps were performed with EMG registration at rest and after each sprint. Running velocity (P less than 0.001) and stride length (P less than 0.05) decreased and contact time increased (P less than 0.01) during the 400-m sprint. The increase in contact time was greatest immediately after runs of 100 and 300 m. The peak BLa increased and the rate of BLa accumulation decreased with running distance (P less than 0.001). The height of rise of the centre of mass in the drop jumps was smaller immediately after the 300 m (P less than 0.05) and the 400 m (P less than 0.01) than at rest, and it correlated negatively with peak BLa (r = -0.77, P less than 0.001). The EMG and EMG:running velocity ratio increased with running distance. It was concluded that force generation of the leg muscles had already begun to decrease during the first quarter of the 400-m sprint. The deteriorating force production was compensated for until about 200-300 m. Thereafter, it was impossible to compensate for fatigue and the speed of running dropped. According to this study, fatigue in the 400-m sprint among trained athletes is mainly due to processes within skeletal muscle rather than the central nervous system.

Adult

Physiological performance capacity in different prepubescent athletic groups.

Endurance, strength and speed capacity were investigated among prepubescent male weight lifters (EL), endurance runners (ER) and sprint runners (SR). The subjects were selected by their coaches and all of them were classified as promising and successful junior athletes in the age groups of 10-13 years. Twelve boys belonged to athletic group (AG) and their performance capacity was compared to normally active control (C) boys (n = 9). Biological age was significantly (p less than 0.05) greater in AG (11.3 +/- 0.9 years) than in C (10.2 +/- 1.4 years) but in chronological age there was no difference between the groups. Maximal oxygen uptake was significantly (p less than 0.05) higher in AG (62.3 +/- 3.1 ml.kg-1.min-1) than in C (55.4 +/- 7.7 ml.kg-1.min-1). The endurance runners had the highest value (66.5 +/- 2.9 ml.kg-1.min-1). In anaerobic characteristics there were no significant differences. The rise of centre of gravity (0.26 +/- 0.03 m) of AG in a test for the best drop jump was clearly (p less than 0.05) higher than that (0.22 +/- 0.03 m) of C. The weight lifters and sprint runners were the best in the test for force production. AG had significantly (p less than 0.01) shorter choice reaction time (261 +/- 39 ms) than C (344 +/- 81 ms). Testosterone correlated with jump performances (p less than 0.05), biological age (p less than 0.01) and chronological age (p less than 0.001). Growth hormone correlated significantly only with biological age (p less than 0.05) and testosterone (p less than 0.001). In conclusion, endurance capacity (aerobic) and strength capacity were greater in the athletic group than in the control group and it was suggested that training background and more advanced biological maturation of the athletes affected especially their strength capacity. The parameters used in this investigation can be utilized for talent selection in sport.

Adolescent

Heart rate and exercise intensity during sports activities. Practical application.

Variations in heart rate during exercise correlate with changes of exercise intensity and may be measured directly by radiotelemetry and continuous ECG recording. The heart rate can also be recorded in the memory of a microcomputer, which can be carried on the wrist as easily as a watch. The device has a transmitter and a receiver. By recording the heart rate during a training session or a segment of training, and calculating the average of the heart rate and comparing this average to both the maximum heart rate of the individual and his heart rate at rest, the relative heart rate to the intensity of the work load (% maximum heart rate) can be calculated. These results are useful in planning optimal training intensities for both the healthy and rehabilitating athlete. The use of target heart rate as a tool for exercise prescription is common. It represents the percentage difference between resting and maximum heart rate added to the resting heart rate. For calculating target heart rate there are also 2 other methods. The first represents the percentage of the maximum heart rate (%HRmax) calculated from zero to peak heart rate. The second represents the heart rate at a specified percentage of maximum MET (VO2max). An appropriate individual heart rate for each level of an endurance performance is best determined in the laboratory. This is carried out by increasing the speed of the runner in stages on a treadmill and by measuring the oxygen uptake, the lactic acid concentration in the blood and corresponding variations in the heart rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Electrocardiography

A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.

A solid-phase radioimmunoassay (RIA) was used to determine the presence of IgG and IgM antibodies to measles virus in human serum and cerebrospinal fluid (CSF). Purified measles virus was adsorbed on to polystyrene balls, which were then exposed to serial dilutions of test serum or CSF. The presence of antibody was measured by its capacity to bind 125I-labelled specific anti-human IgG or IgM. Serum from a variety of patients as well as measles-immune clinically healthy persons were tested; binding ratios (using negative human serum controls) were usually between 10 and 30, but with subacute sclerosing panencephalitis (SSPE) ratios were as high as 50. Of ten CSF specimens tested, all but one, which was taken early in the convalescent phase of measles infection, had detectable IgG antibody. In six patients with acute measles, IgM antibodies were found in all serum specimens taken one or more days after the onset of rash. Maximal titers of 1:10000 to 1:40000 were found about 7 days later. Thereafter, IgM titres decreased rapidly but were still detectable at 40 days. A purified ribonucleoprotein of measles virus was also used successfully as an antigen in this RIA method.

Antibodies, Viral